Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kim Boesen

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
JAMA Psychiatry|March 24, 2016
Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking MethylphenidateKim Boesen, Peter C Gøtzsche
Journal of Evaluation in Clinical Practice|February 22, 2023
Medical advertisements and scientific journals: Time for editors and publishers to take a stanceKim Boesen, John P A Ioannidis
Lancet (London, England)|September 29, 2018
Network meta-analysis of antidepressantsKim Boesen, Asger Sand Paludan-Müller, Klaus Munkholm
Journal of the Royal Society of Medicine|March 24, 2021
The US Food and Drug Administration's authorisation of Purdue's controlled-release methylphenidate for adult ADHD: comments on the regulatory practiceKim Boesen, Karsten Juhl Jørgensen, Peter C Gøtzsche
BMJ Open|June 29, 2019
Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysisKlaus Munkholm, Asger Sand Paludan-Müller, Kim Boesen
Journal of Clinical Epidemiology|December 22, 2021
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: A case study of public documents: author's replyKim Boesen, Karsten Juhl Jørgensen, Peter C Gøtzsche
Journal of Clinical Epidemiology|November 9, 2021
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documentsKim Boesen, Karsten Juhl Jørgensen, Peter C Gøtzsche
Lancet (London, England)|October 9, 2019
Pharmacological treatments for generalised anxiety disorderKlaus Munkholm, Kim Boesen, Asger S Paludan-Müller
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Publicly available continuously updated topic specific databases of randomised clinical trials: A scoping reviewKim Boesen, Lars G Hemkens, Perrine Janiaud, et al.
Clinical Trials (London, England)|January 5, 2026
Topic-specific living databases of clinical trials: A scoping review of public databasesKim Boesen, Lars G Hemkens, Perrine Janiaud, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
JAMA Psychiatry|March 24, 2016
Quality of Life of Adult Patients With Attention-Deficit/Hyperactivity Disorder Taking MethylphenidateKim Boesen, Peter C Gøtzsche
Journal of Evaluation in Clinical Practice|February 22, 2023
Medical advertisements and scientific journals: Time for editors and publishers to take a stanceKim Boesen, John P A Ioannidis
Lancet (London, England)|September 29, 2018
Network meta-analysis of antidepressantsKim Boesen, Asger Sand Paludan-Müller, Klaus Munkholm
Journal of the Royal Society of Medicine|March 24, 2021
The US Food and Drug Administration's authorisation of Purdue's controlled-release methylphenidate for adult ADHD: comments on the regulatory practiceKim Boesen, Karsten Juhl Jørgensen, Peter C Gøtzsche
BMJ Open|June 29, 2019
Considering the methodological limitations in the evidence base of antidepressants for depression: a reanalysis of a network meta-analysisKlaus Munkholm, Asger Sand Paludan-Müller, Kim Boesen
Journal of Clinical Epidemiology|December 22, 2021
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: A case study of public documents: author's replyKim Boesen, Karsten Juhl Jørgensen, Peter C Gøtzsche
Journal of Clinical Epidemiology|November 9, 2021
Clinical trials were missing from regulatory documents of extended-release methylphenidate for ADHD in adults: a case study of public documentsKim Boesen, Karsten Juhl Jørgensen, Peter C Gøtzsche
Lancet (London, England)|October 9, 2019
Pharmacological treatments for generalised anxiety disorderKlaus Munkholm, Kim Boesen, Asger S Paludan-Müller
Medrxiv : the Preprint Server for Health Sciences|November 28, 2024
Publicly available continuously updated topic specific databases of randomised clinical trials: A scoping reviewKim Boesen, Lars G Hemkens, Perrine Janiaud, et al.
Clinical Trials (London, England)|January 5, 2026
Topic-specific living databases of clinical trials: A scoping review of public databasesKim Boesen, Lars G Hemkens, Perrine Janiaud, et al.
Pageof 3